Cambridge Nutritional Sciences PLC (CNSL) has received a major shareholding notification confirming that Julian Hanton crossed a voting rights threshold in the company on 3 November 2026. The TR-1 form, filed with the issuer and the FCA on 5 November 2026, reveals Hanton's total holding rose to 4.959011% of voting rights, up from a previous position of 3.004825%. The shares are held indirectly through Hargreaves Lansdown (Nominees) Limited, based in Bristol, and Pershing Nominees Limited, based in Liverpool. Investors in the AIM-quoted nutritional sciences business may be watching to assess whether the increased stake signals growing institutional or individual conviction in the company.

Key Points

  • Cambridge Nutritional Sciences PLC (CNSL), a UK-listed nutritional sciences company
  • Julian Hanton's voting rights stake increased to 4.959011%, crossing a regulatory disclosure threshold on 3 November 2026
  • Total shares held: 11,800,000 ordinary shares (ISIN: GB00B1VCP282); previous notification stood at 3.004825%
  • Investors may watch for any further threshold crossings or additional disclosures from Hanton or associated nominees

Julian Hanton's Stake in Cambridge Nutritional Sciences Rises from 3.00% to 4.96%

The TR-1 notification confirms that Julian Hanton's total position in Cambridge Nutritional Sciences PLC increased materially compared with his previous filing. His holding moved from 3.004825% to 4.959011% of total voting rights, representing 11,800,000 ordinary shares in the company. The acquisition of voting rights is cited as the reason for the notification, with no financial instruments such as options or contracts for difference forming part of the disclosed position. The shares carry the ISIN code GB00B1VCP282 and are classified as direct holdings under DTR5.1 of the FCA's Disclosure Guidance and Transparency Rules.

Hargreaves Lansdown and Pershing Nominees Named as Registered Holders

The notification identifies two nominee entities through which the voting rights are effectively held on Hanton's behalf. Hargreaves Lansdown (Nominees) Limited is registered in Bristol, UK, whilst Pershing Nominees Limited is registered in Liverpool, UK. Both are well-established nominee and custody service providers used by retail and professional investors across UK markets. The disclosure confirms that Hanton is not controlled by any natural person or legal entity and does not himself control any other undertaking holding an interest in Cambridge Nutritional Sciences, as indicated in section nine of the TR-1 form.

Regulatory Timeline: Threshold Crossed 3 November, Issuer Notified 5 November 2026

Under UK transparency rules, major shareholders are required to notify the issuer and the FCA when their voting rights cross prescribed thresholds. In this instance, the threshold was crossed or reached on 3 November 2026, with the issuer formally notified on 5 November 2026. The TR-1 form was completed in the UK on 5 November 2026. Cambridge Nutritional Sciences subsequently released the disclosure via the Regulatory News Service on 9 November 2026, fulfilling its obligation to make the information available to the wider market in a timely manner.

What the Disclosure Means for Cambridge Nutritional Sciences Shareholders

Major shareholding notifications of this nature are a standard feature of UK-listed company governance, providing transparency around significant ownership changes. For existing Cambridge Nutritional Sciences shareholders, the disclosure indicates that one individual now holds just under 5% of the company's voting rights, a level that is approaching the next commonly watched 5% disclosure threshold. The company did not disclose any commentary on the transaction in the announcement, and no changes to board composition, strategy, or financial guidance were referenced within the notification filing.